These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26617762)

  • 1. Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples.
    Fujimoto Y; Togo S; Tulafu M; Shimizu K; Hayashi T; Uekusa T; Honma Y; Namba Y; Takamochi K; Oh S; Suzuki K; Takahashi K
    Int J Clin Exp Pathol; 2015; 8(9):10523-33. PubMed ID: 26617762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
    Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
    Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
    Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
    Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
    J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
    J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
    Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
    Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
    Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.
    Jakobsen JN; Santoni-Rugiu E; Ravn J; Sørensen JB
    Eur J Cancer; 2013 Jul; 49(11):2494-503. PubMed ID: 23639410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
    Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
    Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Oskarsdottir GN; Bjornsson J; Jonsson S; Isaksson HJ; Gudbjartsson T
    APMIS; 2016 May; 124(5):384-92. PubMed ID: 26957057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between lung adenocarcinoma histological subtype and patient prognosis.
    Urer HN; Kocaturk CI; Gunluoglu MZ; Arda N; Bedirhan MA; Fener N; Dincer SI
    Ann Thorac Cardiovasc Surg; 2014; 20(1):12-8. PubMed ID: 23364232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.